162 related articles for article (PubMed ID: 12083402)
21. SNP databases and pharmacogenetics: great start, but a long way to go.
Marsh S; Kwok P; McLeod HL
Hum Mutat; 2002 Sep; 20(3):174-9. PubMed ID: 12203989
[TBL] [Abstract][Full Text] [Related]
22. An interview with Peter J. Coassin. Interview by Vicki Glaser.
Coassin PJ
Assay Drug Dev Technol; 2005 Apr; 3(2):125-31. PubMed ID: 15871687
[No Abstract] [Full Text] [Related]
23. Deconstructing Myogen's market cap.
Ransom J
Nat Biotechnol; 2006 Mar; 24(3):227-8. PubMed ID: 16525363
[No Abstract] [Full Text] [Related]
24. [A high-throughput SNP typing system for genome-wide association studies].
Ohnishi Y
Gan To Kagaku Ryoho; 2002 Nov; 29(11):2031-6. PubMed ID: 12465410
[TBL] [Abstract][Full Text] [Related]
25. Building biomanufacturing capacity--the chapter and verse.
Kamarck ME
Nat Biotechnol; 2006 May; 24(5):503-5. PubMed ID: 16680126
[TBL] [Abstract][Full Text] [Related]
26. Biotech jostles with pharma for slice of HIV market.
Katsnelson A
Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
[No Abstract] [Full Text] [Related]
27. First phase of HapMap project already helping drug discovery.
Andrawiss M
Nat Rev Drug Discov; 2005 Dec; 4(12):947. PubMed ID: 16370072
[No Abstract] [Full Text] [Related]
28. The market for follow-on biologics: how will it evolve?
Grabowski H; Cockburn I; Long G
Health Aff (Millwood); 2006; 25(5):1291-301. PubMed ID: 16966725
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics and genotyping: on the trail of SNPs.
Melton L
Nature; 2003 Apr; 422(6934):917, 919, 921, 923. PubMed ID: 12712209
[No Abstract] [Full Text] [Related]
30. The Human Genome Project: a public good.
Hudson K
Health Matrix Clevel; 2002; 12(2):367-75. PubMed ID: 12430360
[No Abstract] [Full Text] [Related]
31. Pharmacogenetic analysis of clinically relevant genetic polymorphisms.
McLeod HL
Clin Infect Dis; 2005 Nov; 41 Suppl 7():S449-52. PubMed ID: 16237646
[TBL] [Abstract][Full Text] [Related]
32. The view from the top.
Howard K
Nature; 2003 Dec; 426(6967):696-7. PubMed ID: 14668873
[No Abstract] [Full Text] [Related]
33. Pharmacogenomics.
Nat Biotechnol; 2000 Oct; 18 Suppl():IT40-2. PubMed ID: 11221715
[No Abstract] [Full Text] [Related]
34. Overcoming the challenges in the pharma/biotech industry.
Graul AI; Prous JR
Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenetics initiative galvanizes public and private sectors.
Smaglik P
Nat Biotechnol; 2001 Jul; 19(7):691-2. PubMed ID: 11433290
[No Abstract] [Full Text] [Related]
36. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
[No Abstract] [Full Text] [Related]
37. Designs that enrich lives.
Link A; Stark H
Arch Pharm (Weinheim); 2007 Oct; 340(10):509-10. PubMed ID: 17912676
[No Abstract] [Full Text] [Related]
38. Best-selling human medicines 2002-2004.
Maggon K
Drug Discov Today; 2005 Jun; 10(11):739-42. PubMed ID: 15922927
[No Abstract] [Full Text] [Related]
39. Pharma focus. Gene genies.
Jones A
Health Serv J; 2003 Nov; 113(5883):suppl 8. PubMed ID: 14671869
[No Abstract] [Full Text] [Related]
40. Pharmacogenomic discovery approaches: will the real genes please stand up?
Walgren RA; Meucci MA; McLeod HL
J Clin Oncol; 2005 Oct; 23(29):7342-9. PubMed ID: 16145062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
